Citadel Advisors’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-42,794
| Closed | -$184K | – | 7305 |
|
|
2022
Q3 | $184K | Buy |
42,794
+27,667
| +183% | +$119K | ﹤0.01% | 4891 |
|
|
2022
Q2 | $62K | Buy |
+15,127
| New | +$62K | ﹤0.01% | 5442 |
|
|
2021
Q2 | – | Sell |
-2,373
| Closed | -$59K | – | 7572 |
|
|
2021
Q1 | $59K | Buy |
+2,373
| New | +$59K | ﹤0.01% | 6053 |
|
|
2020
Q1 | – | Sell |
-55
| Closed | -$9K | – | 5634 |
|
|
2019
Q4 | $9K | Buy |
+55
| New | +$9K | ﹤0.01% | 4560 |
|
|
2019
Q3 | – | Sell |
-43
| Closed | -$24K | – | 5444 |
|
|
2019
Q2 | $24K | Buy |
43
+15
| +54% | +$8.37K | ﹤0.01% | 4481 |
|
|
2019
Q1 | $33K | Buy |
+28
| New | +$33K | ﹤0.01% | 4333 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 4400 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4369 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4217 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4312 |
|
|
2015
Q4 | – | Hold |
0
| – | -$13K | – | 4509 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 3855 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 4326 |
|